Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]
, 2012 BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R +26 more
core +1 more source
Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study. [PDF]
, 2014 OBJECTIVE: To use patient-level data from the ADVANCE study to evaluate the cost-effectiveness of transcatheter aortic valve implantation (TAVI) compared to medical management (MM) in patients with severe aortic stenosis from the perspective of the UK ...
Busca, R +32 more
core +1 more source
Role of natriuretic peptides in the assessment of aortic stenosis severity [PDF]
Vojnosanitetski Pregled, 2010 Background/Aim. Symptom onset is a critical point in natural course of aortic stenosis and the most important indication for aortic valve replacement.
Davičević Žaklina +4 more
doaj +1 more source
Transcatheter versus surgical aortic-valve replacement in high-risk patients. [PDF]
, 2011 BACKGROUND: The use of transcatheter aortic-valve replacement has been shown to reduce mortality among high-risk patients with aortic stenosis who are not candidates for surgical replacement.
Makkar, Raj R +47 more
core +1 more source
Interdisciplinary three-step strategy to treat aortic stenosis and coronary artery disease in a patient with end-stage chronic obstructive pulmonary disease [PDF]
, 2012 Background: Valvular aortic stenosis is a common disease in the elderly, often in multimorbid patients. It is often associated with coronary artery disease and peripheral artery disease.
Michel, Sebastian +6 more
core +1 more source
Timing of Intervention in Asymptomatic Patients with Aortic Stenosis
European Cardiology Review, 2021 Aortic stenosis is a very common disease. Current guidelines recommend intervention mainly in symptomatic patients; aortic valve replacement can be considered in asymptomatic patients under specific conditions, but the evidence supporting these ...
Teresa Sevilla +2 more
doaj +1 more source
Successful emergency transcatheter aortic valve replacement in the setting of hemodynamically unstable prosthetic aortic valve stenosis [PDF]
Journal of Cardiovascular and Thoracic Research, 2022 FDA approved transcatheter aortic valve replacement (TAVR) for the treatment of symptomatic aortic valve (AV) stenosis. Recent evidence reveals that TAVR is the treatment of choice in most patients with AV stenosis who are at high risk for surgical ...
Muhammad Ishaq +6 more
doaj +1 more source
Management of Asymptomatic Severe Aortic Stenosis [PDF]
Current Cardiology Reviews, 2009 Patients with symptomatic severe aortic stenosis (AS) benefit from aortic valve replacement surgery, but the management of patients with asymptomatic severe AS is more controversial. While cholesterol and angiotensin have been linked to AS progression, we should await the results of ongoing randomized trials before medical therapy to lower cholesterol ...
Stewart, Robert L., Chan, Kwan L.
openaire +2 more sources
High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis [PDF]
, 2014 AIMS: High-sensitivity cardiac troponin I (cTnI) assays hold promise in detecting the transition from hypertrophy to heart failure in aortic stenosis.
Lang, Chim C. +30 more
core +1 more source
A case control investigation of the relation between hyperlipidaemia and calcific aortic valve stenosis [PDF]
, 1997 Objective To investigate the relation of hyperlipidaemia to calcific aortic valve stenosis. Design A case-control study designed to detect a clinically relevant difference in the fasting plasma concentrations of total cholesterol between the groups at ...
Stevenson, R N +3 more
core +1 more source